Abstract | INTRODUCTION: AREAS COVERED: Studies on the pharmacological characteristics of cangrelor and clinical trials were retrieved by a PubMed literature search. EXPERT OPINION:
|
Authors | Eleonora Tamborini Permunian, Nicoletta Riva, Luigina Guasti, Alessandro Squizzato |
Journal | Expert opinion on drug metabolism & toxicology
(Expert Opin Drug Metab Toxicol)
Vol. 11
Issue 4
Pg. 625-37
(Apr 2015)
ISSN: 1744-7607 [Electronic] England |
PMID | 25728292
(Publication Type: Journal Article, Review)
|
Chemical References |
- Platelet Aggregation Inhibitors
- Adenosine Monophosphate
- cangrelor
|
Topics |
- Adenosine Monophosphate
(adverse effects, analogs & derivatives, pharmacology, therapeutic use)
- Coronary Artery Disease
(therapy)
- Hemorrhage
(chemically induced)
- Humans
- Percutaneous Coronary Intervention
(methods)
- Platelet Aggregation Inhibitors
(adverse effects, pharmacology, therapeutic use)
- Thrombosis
(drug therapy, pathology)
|